GlassScriptPhysician profile
Matthew Fort
NPI 1760801039
$6,300.84
in general payments reported to CMS, 2019-2025
18 companies · $1,017 in 2025
The $1,017 reported for 2025 was more than what 80% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $25.00 · 2021: $49.30 · 2022: $546 · 2023: $3,193 · 2024: $1,030 · 2025: $1,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,008 · Travel and Lodging: $2,133 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,008.25 |
| Travel and Lodging | $2,132.84 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,907.13 | 2019-2024 | Coblation, Tula, Trigen |
| Glaxosmithkline, LLC. | $517.47 | 2021-2025 | Nucala |
| Genzyme Corporation | $515.12 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $510.71 | 2019-2025 | Dupixent |
| Inspire Medical Systems, INC. | $402.44 | 2022-2025 | Inspire |
| Cochlear Americas | $338.00 | 2023-2024 | Baha, Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Optinose US, INC. | $281.08 | 2022-2025 | |
| Osiris Therapeutics INC. | $211.32 | 2019 | |
| Advanced Bionics, LLC | $160.07 | 2022-2023 | Hires Ultra Ci Hifocus Ms Electrode |
| Aerin Medical INC. | $154.00 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $98.99 | 2025 | |
| Acclarent, INC | $69.72 | 2023 | Acclarent Aera |
| Med-El Corporation | $31.40 | 2024 | Bci 602 Kit, Mi1250 Synchrony 2 Flexsoft |
| Amgen INC. | $24.67 | 2025 | Tezspire |
| Intersect Ent, INC. | $21.98 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $21.58 | 2023 | |
| Alk-Abello, INC | $18.17 | 2022 | |
| Paratek Pharmaceuticals, INC. | $16.99 | 2025 | Xhance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Fort listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.